| abstract |
FIELD: medicine. n SUBSTANCE: present invention concerns a compound representing a selective agonist of a melanocortin-4 receptor of formula: Ac-Arg-c(Cys-D-Ala-His-D-Phe-Arg-Trp-Cys)-NH 2 (SEQ ID NO:50) and its pharmaceutically acceptable salts, pharmaceutical compositions and methods for application thereof in preparation of drugs. n EFFECT: higher effectiveness of compound application. n 20 cl, 8 dwg, 4 tbl, 4 ex |